OS Therapies Incorporated (OSTX)
XASE:OSTX
Total Valuation
OS Therapies Incorporated has a market cap or net worth of $49.65M. The enterprise value is -$221.94M.
Market Cap$49.65M
Enterprise Value-$221.94M
Share Statistics
OS Therapies Incorporated has 35,214,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,214,350
Owned by Insiders18.37%
Owned by Institutions1.35%
Financial Efficiency
OS Therapies Incorporated’s return on equity (ROE) is -26.86 and return on invested capital (ROIC) is 545.96%.
Return on Equity (ROE)-26.86
Return on Assets (ROA)-4.42
Return on Invested Capital (ROIC)545.96%
Return on Capital Employed (ROCE)5.46
Revenue Per Employee0.00
Profits Per Employee-7.19B
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OS Therapies Incorporated is ―. OS Therapies Incorporated’s PEG ratio is -0.00002.
PE Ratio―
PS Ratio0.00
PB Ratio0.04
Price to Fair Value0.04
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio-0.00002
Income Statement
In the last 12 months, OS Therapies Incorporated had revenue of 0.00 and earned -28.75B in profits. Earnings per share was -0.98.
Revenue0.00
Gross Profit0.00
Operating Income-28.71B
Pretax Income-28.75B
Net Income-28.75B
EBITDA-28.71B
Earnings Per Share (EPS)-0.98
Cash Flow
In the last 12 months, operating cash flow was -14.24B and capital expenditures 0.00, giving a free cash flow of -14.24B billion.
Operating Cash Flow-14.24B
Free Cash Flow-14.24B
Free Cash Flow per Share-404.34
Dividends & Yields
OS Therapies Incorporated pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.05
52-Week Price Change-6.62%
50-Day Moving Average1.41
200-Day Moving Average1.74
Relative Strength Index (RSI)47.72
Average Volume (3m)444.71K
Important Dates
OS Therapies Incorporated upcoming earnings date is Apr 6, 2026, Before Open (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateApr 6, 2026
Ex-Dividend Date―
Financial Position
OS Therapies Incorporated as a current ratio of 0.03, with Debt / Equity ratio of 0.00%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, OS Therapies Incorporated has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
OS Therapies Incorporated EV to EBITDA ratio is <0.01, with an EV/FCF ratio of 0.02.
EV to Sales0.00
EV to EBITDA<0.01
EV to Free Cash Flow0.02
EV to Operating Cash Flow0.02
Balance Sheet
OS Therapies Incorporated has $269.83M in cash and marketable securities with $0.00 in debt, giving a net cash position of $269.83M billion.
Cash & Marketable Securities$269.83M
Total Debt$0.00
Net Cash$269.83M
Net Cash Per Share$7.66
Tangible Book Value Per Share$219.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for OS Therapies Incorporated is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside594.44% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast-133.00%